title: Circulating vascular endothelial growth factor and nitric oxide in patients with liver cirrhosis: A possible association with liver function impairment.
abstract: Hemodynamic disorders of liver cirrhosis complicated with portal hypertension are associated with an increased angiogenesis in animal model of portal hypertension and cirrhosis which were linked to increased expression of vascular endothelial growth factor (VEGF) and nitric oxide (NO). The aim of study was to evaluate the serum concentration of VEGF and total nitric oxide (NO) in liver cirrhosis and the possible association with the degree of liver insufficiency. VEGF and NO were measured in serum of 64 patients with liver cirrhosis by ELISA and spectrophotometry respectively. The significant increase of serum VEGF was observed in liver cirrhosis compared to healthy individuals as well as serum NO (106.1 ± 66.7 vs. 41.5 ± 6 pg/mL, P < 0.05; 113.5 ± 65.8 vs. 20.8 ± 3.8 μmol/l, P< 0.001, respectively). Serum VEGF and NO showed significant associations with biochemical indices of liver function and with Child-pugh score where they were increased respectively to the degree of liver insufficiency. A significant association of raised serum NO in early stage of portal hypertension reflect its benefit in early expect of portal hypertension but, high serum VEGF in late stage may reflect its prognostic value in liver cirrhosis.
authors.affiliation: Department of Biochemistry, Sohag Faculty of Medicine, Sohag University, Sohag, Egypt.
authors.forename: Mohamed Ahmed
authors.initials: MA
authors.lastname: Abdelmoaty
authors.forename: Ahmed Mohamed
authors.initials: AM
authors.lastname: Bogdady
authors.forename: Mervat Mohamed
authors.initials: MM
authors.lastname: Attia
authors.forename: Nayel Abdelhamed
authors.initials: NA
authors.lastname: Zaky
keywords: Liver cirrhosis; Nitric oxide; Portal hypertension; Vascular Endothelial Growth Factor